Acquisition Opportunity UroMed is no longer in business and customers have been redirected to Edgepark, indicating a transition of accounts and potential cross-sell or upsell opportunities for Edgepark's broader healthcare services and product lines.

Integrated Platform Edgepark appears to be absorbing UroMed customers, suggesting a chance to align and upsell complementary medical supplies, patient support services, or digital fulfillment capabilities using Edgepark's existing platform and tech stack.

Scale Potential With Edgepark likely serving a larger customer base post-acquisition and UroMed’s prior revenue footprint, there is potential to target similar mid-market hospital and supply chain customers for partnerships or enterprise deals.

Tech Enablement The listed tech stack (OneTrust, Osano, Adobe Experience Cloud, Dynatrace, iCIMS, Mautic, etc.) indicates mature digital operations; sales pitches can emphasize security, privacy compliance, and personalized digital experiences to win similar customers.

Financial Signals Revenue range for UroMed ($25M-$50M) combined with its closure suggests a strategic consolidation in the market; position offerings as cost-effective, scalable solutions to capture a portion of the displaced budget within Edgepark’s extended customer base.